-
1
-
-
0033808034
-
Potential influence of lipids in diabetic nephropathy: Insight from experiment data to clinical studies
-
Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: insight from experiment data to clinical studies[J]. Diab Metab, 2000,26(4):254-264.
-
(2000)
Diab Metab
, vol.26
, Issue.4
, pp. 254-264
-
-
Bonnet, F.1
Cooper, M.E.2
-
2
-
-
0032737294
-
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
-
Rychlik RE, Locatelli K. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions[J]. Am J Kidney Dis, 1999,34(6):795-808.
-
(1999)
Am J Kidney Dis
, vol.34
, Issue.6
, pp. 795-808
-
-
Rychlik, R.E.1
Locatelli, K.2
-
3
-
-
0033997144
-
Studies of renal injury III: Lipid-induced nephropathy in type 2 diabetes
-
Dominguez JH, Tang NJ, Wei X, et al. Studies of renal injury III: Lipid-induced nephropathy in type 2 diabetes[J]. Kidney Int, 2000,57(1):92-104.
-
(2000)
Kidney Int
, vol.57
, Issue.1
, pp. 92-104
-
-
Dominguez, J.H.1
Tang, N.J.2
Wei, X.3
-
4
-
-
0037965858
-
Diabetes: Mellitus or lipidus
-
Shafrir K, Raz I. Diabetes: mellitus or lipidus[J]. Diabetologia, 2003,46(2):433-440.
-
(2003)
Diabetologia
, vol.46
, Issue.2
, pp. 433-440
-
-
Shafrir, K.1
Raz, I.2
-
5
-
-
0038119554
-
Effects of the combination of an angoitensin II antagonist with an HMG-COM reductase inhibitor in experimental diabetes
-
Qin J, Zhang ZL, Liu J, et al. Effects of the combination of an angoitensin II antagonist with an HMG-COM reductase inhibitor in experimental diabetes[J]. kidney Int, 2003,64(2):565-571.
-
(2003)
Kidney Int
, vol.64
, Issue.2
, pp. 565-571
-
-
Qin, J.1
Zhang, Z.L.2
Liu, J.3
-
6
-
-
0034608948
-
Long-term prevention of renalinsufficiency. Excess matrix gene expression and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth facor-beta antibody in db/db diabetic mice
-
Ziyadeh KN, Hoffman BB, Han DC, et al. Long-term prevention of renalinsufficiency. Excess matrix gene expression and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth facor-beta antibody in db/db diabetic mice [J]. Proc. Natl Acad Sci. 2000,97(11):8015-8020.
-
(2000)
Proc Natl Acad Sci
, vol.97
, Issue.11
, pp. 8015-8020
-
-
Ziyadeh, K.N.1
Hoffman, B.B.2
Han, D.C.3
-
7
-
-
0029924637
-
Neutralization of TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice
-
Sharma K, Jin Y, Ziyadeh FN. Neutralization of TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice[J]. Diabetes, 1996,45(3):522-530.
-
(1996)
Diabetes
, vol.45
, Issue.3
, pp. 522-530
-
-
Sharma, K.1
Jin, Y.2
Ziyadeh, F.N.3
-
8
-
-
0031911356
-
Smad: Mediators and regulators of TGF-Beta signaling
-
Kretzschmar M, Massague J. Smad: Mediators and regulators of TGF-Beta signaling[J]. Curr opin Gene. 2000,8(1):103-111.
-
(2000)
Curr Opin Gene
, vol.8
, Issue.1
, pp. 103-111
-
-
Kretzschmar, M.1
Massague, J.2
-
9
-
-
0034087307
-
Stimulation of TGF-b type II receptor by high glucose\in mouse mesangial cells and in diabetic kidney
-
Motohide IN, Mogyorosi A, Han DC, et al. Stimulation of TGF-b type II receptor by high glucose\in mouse mesangial cells and in diabetic kidney[J]. Am J Physiol Renal Physiol, 2000,278(5): 830-838.
-
(2000)
Am J Physiol Renal Physiol
, vol.278
, Issue.5
, pp. 830-838
-
-
Motohide, I.N.1
Mogyorosi, A.2
Han, D.C.3
|